Jonathan Mark Hopper sold $495k of VCEL
Chief Medical Officer at Vericel Corp. 10,000 shares at an average of $49.53, traded Mar 3, 2025, filed Mar 5, 2025.
Score components
- +15RoleOfficer
- +18Trade size$495k at market
- +5Share of holdings soldSold 13% of holdings
- +15Cluster5 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001140361-25-007179, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 3, 2025 | MOption exercise Common Stock10b5-1 | +10,000 | $18.00 | $180k | 76,101 | Mar 5, 2025 |
| Mar 3, 2025 | SOpen-market sale Common Stock10b5-1 | -10,000 | $49.53 | $495k | 66,101 | Mar 5, 2025 |
| Mar 3, 2025 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | +10,000 | $0.00 | $0 | 28,750 | Mar 5, 2025 |
Related signals
Other insiders at Vericel Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 8Weak | Vericel Corp | Heidi Hagen director | $486k 15,000 shares | -32% | |
| 30Weak | Vericel Corp | Sean C. Flynn Chief Legal Officer | $754k 21,421 shares | -279% | |
| 33Weak | Vericel Corp | Michael Halpin Chief Operating Officer | $364k 10,305 shares | -39% | |
| 3Weak | Vericel Corp | Kevin F McLaughlin director | $243k 7,000 shares | -32% | |
| 11Weak | Vericel Corp | Michael Halpin Chief Operating Officer | $405k 10,000 shares | -38% | |
| 0Weak | Vericel Corp | Jonathan Mark Hopper Chief Medical Officer | $65k 1,652 shares | -2% | |
| 40Moderate | Vericel Corp | Paul K Wotton director | $190k 5,000 shares | -16% | |
| 8Weak | Vericel Corp | Michael Halpin Chief Operating Officer | $107k 2,642 shares | -14% | |
| 11Weak | Vericel Corp | Kevin F McLaughlin director | $270k 7,000 shares | -32% | |
| 17Weak | Vericel Corp | Michael Halpin Chief Operating Officer | $298k 7,358 shares | -32% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.